Earningsreport

Q3/2023 9/30/2023 EPS -0.090 ZacksConsensus -0.130 ActVsEst 0.040 - Beat

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx